Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Zentek Ltd - ZEN -- Ignore unavailable to you. Want to Upgrade?

To: hoov who wrote (2585)	8/25/2013 7:01:32 PM
From: pop123	Read Replies (1) \| Respond to of 22791

HOOV,when the 43-101 comes out i understand that things change for how AE can speak about the deposit. he may be sure of what he has.but without a 43-101 complete he is limited in how he describes the asset. all indications are that it will turn out well.i am looking forward to the change in tone from AE when the paperwork is in place do you think there will be a change ??

To: hoov who wrote (2585)	8/25/2013 9:38:01 PM
From: vitalremains	Read Replies (1) \| Respond to of 22791

Much appreciate the info. I understand you're not sure but sounds like it's possible that purity info has been received from a university or a commercial lab but nothing is to be released until they've received all studies pending (if there's even more than one study being conducted as you've "heard"). This sounds great in theory as you wouldn't want any research influenced and have biased results. However this is a difficult scenario to pull off as it's practically impossible to completely prevent information leakage and insider trading. If they are waiting on numerous studies and plan on releasing any information once all data is compiled I would suggest they confirm with regulators that they're following a proper course of action. I would hope we can all agree that the primary concern here is maximizing shareholder value. And I think this is more likely from having results periodically released as received (running the risk of minor bias in other current pending studies) compared to having information leakage, insider trading and a compliance investigation down the road.